focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,130.00
Bid: 12,130.00
Ask: 12,132.00
Change: -36.00 (-0.30%)
Spread: 2.00 (0.016%)
Open: 12,186.00
High: 12,198.00
Low: 12,116.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland agrees deal to buy one million vaccines from Romania

Fri, 02nd Jul 2021 16:11

(Alliance News) - Ireland has agreed a deal in principle to purchase one million unwanted vaccines from Romania.

Taoiseach Micheal Martin spoke to the president of Romania, Klaus Iohannis, on Friday and a deal was agreed, but is yet to be finalised.

It will provide a further boost for Ireland's vaccination rollout, following an earlier announcement that it will be accelerated for people aged 18 to 34.

A spokesman for the taoiseach said: "The taoiseach has consistently been making every effort and working with his counterparts across Europe to increase the number of vaccines made available to Ireland.

"As part of this process the taoiseach had a good discussion this morning with his EU counterpart, Romanian president Klaus Iohannis, and they agreed in principle to the purchase of one million vaccines.

"This process is continuing and is yet to be completed. He will continue to work with his government colleagues to expedite the vaccine programme.

"This includes discussions with the European Commission and with member states, particularly those who may have potential surpluses.

"Ensuring that as many people as possible can get vaccinated as quickly as possible remains the best way to combat Covid-19, particularly given the rapid rise of the Delta variant."

The PA news agency understands that the purchase will be made up of the mRNA vaccines Pfizer and Moderna.

Earlier it was announced that people aged 18 to 34 could receive their coronavirus vaccine up to two months early under an accelerated programme announced by the Minister for Health.

It follows updated advice from the National Immunisation Advisory Committee that the AstraZeneca PLC and Johnson & Johnson vaccines can be given to people under 40.

People aged 18 to 34 can now "opt in" for one of those jabs, or choose to wait for an mRNA vaccine such as Pfizer Inc or Moderna Inc.

The opt-in system will run in parallel with the online registration portal, which will open for the 30 to 34-year-old age cohort next Friday.

Health Minister Stephen Donnelly told the Dail that "a significant acceleration of the vaccine programme" will begin from Monday.

He said: "In short, the changes that we're implementing from Monday will mean that the 18 to 34-year-old age group will have the option of being vaccinated one to two months early.

"And that would have been really, really welcome regardless of the Delta variant and this surge, but particularly in light of the modelling we saw from Professor Nolan's team as to what is likely to happen here through August and September in particular.

"To be able to pull forward a huge number of people from September to August, and some from August into July, is incredibly valuable.

"It's really going to help us protecting each other and protect our population from the Delta surge that we know is coming."

It comes after Chief Medical Officer Tony Holohan warned a fourth wave of Covid-19, driven by the Delta variant, cannot be stopped, and will lead to higher levels of hospital admissions and death.

The accelerated vaccine rollout will fail to halt an exponential rise in cases in July and August, he said, but should help bring the situation under control in September.

Donnelly said: "Supplies of Janssen (J&J) and AstraZeneca will be somewhat limited during July, but we expect that supplies will be able to accommodate a significant number of this age group through July."

He said up to 210,000 J&J vaccines will be available in July.

Another 100,000 AstraZeneca jabs will be available, after the outstanding second doses have been administered.

"The company is committed to providing significantly higher amounts than that," Donnelly added.

Donnelly said the estimate for people aged 25 to 29 to get their first dose, should they wait for mRNA, would be early August, with people aged 18 to 24 waiting until mid-August.

That means it would be early to mid-September before they get their second dose and are fully vaccinated.

The accelerated rollout is take to place in pharmacies and vaccination centres across the country.

Donnelly said: "People will be able to seek an appointment in one of over 700 pharmacies across the country for a Janssen vaccine, subject to supply.

"The following week, the week of the 12th of July, 18 to 34-year-olds will also be able to register on the HSE portal for an appointment in a vaccine centre for an earlier vaccination.

"In the main that will be AstraZeneca, and there will be some Janssen supply available as well. The point is, they'll then be vaccinated earlier than if they waited for the mRNA vaccine."

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.